Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer riskManjeet K. Bolla, Sean Whalen, Abhishek Sarkar et al.|Nature Genetics|2017Cited by 642
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastasesMichele Bottosso, Maria Vittoria Dieci, Gaia Griguolo et al.|British Journal of Cancer|2023Cited by 6
122P Abemaciclib in HR+/HER2- metastatic breast cancer: A real-world experienceMichele Bottosso, Valentina Guarneri, Tommaso Giarratano et al.|Annals of Oncology|2021Cited by 2
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort studyFederica Miglietta, Matteo Fassan, Valentina Carraro et al.|Journal of Clinical Pathology|2023Cited by 2